
Keywords: Diabetes; Insulin resistance; Lipodystrophy; LMNA; PPARG; FPLD; familial partial lipodystrophy; TuLip; Turkish Lipodystrophy Study Group; WB-MRI; whole body magnetic resonance imaging; LMNA; lamin A/C; LMNB2; lamin B2; PPARG; peroxisome proliferator activ